SPONSOR: Stephens (128)
To the extent that a health care provider recommends a specific sequence for prescribing and covering drugs to treat a certain condition, this bill establishes new criteria for developing the step protocols. The bill requires the protocols to be designed around peer-reviewed research or some other process that includes feedback from multidisciplinary experts.
The bill also details considerations and protections to be provided to patients who require and request exemptions to the step therapy protocols. These include making the process easy to locate on the website, allowances for likely adverse reactions or other information and experience that indicates the drug will not be effective.
The bill does not prevent the use of generic substitutes.
This bill is similar to HB 2571 (2020).
Statutes affected: